Cwm, LLC Harrow Health, Inc. Transaction History

Cwm, LLC

$23.3 Billion
Q3 2024

A detailed history of Cwm, LLC transactions in Harrow Health, Inc. stock. As of the latest transaction made, Cwm, LLC holds 14 shares of HROW stock, worth $546. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 6 133.33%

Holding current value

$546

Previous $0 Infinity%

% of portfolio

0.0%

Previous 0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2024 Oct 08, 2024	BUY	$20.85 - $46.47 $166 - $371	8 Added 133.33%	14 $1,000
Q2 2024 Jul 09, 2024	BUY	$10.0 - $21.64 $60 - $129	6 New	6 $0

Others Institutions Holding HROW

# of Institutions

176

Shares Held

21.4M

Call Options Held

845K

Put Options Held

717K

Opaleye Management Inc. Boston, MA

3.99M
Shares

$156 Million
32.75% of portfolio
Private Capital Management, LLC Naples, FL

2.16M
Shares

$84.4 Million
11.41% of portfolio
Black Rock Inc. New York, NY

2.15M
Shares

$83.8 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

1.87M
Shares

$72.8 Million
0.0% of portfolio
State Street Corp Boston, MA

731K
Shares

$28.5 Million
0.0% of portfolio

View Full List

About HARROW HEALTH, INC.

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $1.06B
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

More about HROW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account